Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)-induced lymphoproliferative disease and lytic viral replication

Por Bilger, Andrea, Plowshay, Julie, Ma, Shidong, Nawand ar, Dhananjay, Barlow, Elizabeth A., Romero-Masters, James C., Bristol, Jillian A., Li, Zhe, Tsai, Ming-Han, Delecluse, Henri-Jacques, Kenney, Shannon C.
Publicado no Oncotarget (2017)